• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估成人和儿童人群与传染性结膜炎相关的眼部症状的新型患者报告和观察者报告结局评估的内容效度。

Content validity of a novel patient-reported and observer-reported outcomes assessment to evaluate ocular symptoms associated with infectious conjunctivitis in both adult and pediatric populations.

机构信息

Shire, a Takeda company, 300 Shire Way, Lexington, MA, 02421, USA.

ICON PLC, Gaithersburg, MD, 20878, USA.

出版信息

Health Qual Life Outcomes. 2019 Oct 30;17(1):163. doi: 10.1186/s12955-019-1223-9.

DOI:10.1186/s12955-019-1223-9
PMID:31666074
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6820993/
Abstract

BACKGROUND

Acute infectious conjunctivitis is a common condition most frequently caused by viruses or bacteria. Clinical outcome assessments have been used to assess signs and symptoms of bacterial and viral conjunctivitis, but have not been evaluated for content validity. We aimed to develop content-valid patient- (PRO) and observer-reported outcome (ObsRO) instruments to assess symptoms of ocular discomfort associated with viral or bacterial conjunctivitis in adult and pediatric patients.

METHODS

Draft items were developed from a previous review of published studies from 2001 to 2015. Patients and caregivers of patients with a diagnosis of viral or bacterial conjunctivitis within the past 6 months were recruited. Concept elicitation with open-ended questions explored signs and symptoms, followed by cognitive interviewing to assess clarity and relevance of the draft items. Patients aged ≥8 years were interviewed for the PRO; parents/caregivers of children aged 1-10 years were interviewed for the ObsRO. Interviews were conducted in three rounds to allow changes. Concept saturation was documented using a saturation grid. Cognitive interview data were analyzed iteratively and focused on clarity, relevance and inconsistent interpretation of the instrument's content.

RESULTS

Overall, 23 patients or parents/caregivers participated (round 1, n = 10; round 2, n = 6; round 3, n = 7). Data saturation was reached by the 16th interview. The most frequent spontaneously reported signs/symptoms were: discharge, red/pink eyes, itchiness, swelling/puffiness, watery eyes, pain, burning and foreign body sensation. Itching, pain/burning/stinging and foreign body sensation were most commonly reported as the top three most bothersome symptoms. Interview results indicated that items on pain, itching and foreign body sensation for the PRO and pain or discomfort for the ObsRO were relevant to the patients' experience of conjunctivitis and were clear and easy to understand.

CONCLUSIONS

PRO and ObsRO items were found to be clear, relevant and appropriate in assessing key viral and bacterial conjunctivitis symptoms in adult and pediatric patients.

摘要

背景

急性传染性结膜炎是一种常见病症,通常由病毒或细菌引起。临床结局评估被用于评估细菌性和病毒性结膜炎的体征和症状,但尚未进行内容效度评估。我们旨在开发针对病毒性或细菌性结膜炎患者(PRO)和观察者报告结局(ObsRO)的内容有效的评估工具,以评估与成人和儿童患者眼部不适相关的症状。

方法

从 2001 年至 2015 年发表的研究中进行了文献回顾,以制定草案项目。招募了过去 6 个月内被诊断患有病毒性或细菌性结膜炎的患者和患者的照顾者。通过开放式问题进行概念提取,以探索体征和症状,然后进行认知访谈,以评估草案项目的清晰度和相关性。年龄≥8 岁的患者接受 PRO 访谈;年龄 1-10 岁的儿童的父母/照顾者接受 ObsRO 访谈。访谈分三轮进行,允许进行更改。使用饱和度网格记录概念饱和度。对认知访谈数据进行迭代分析,重点关注工具内容的清晰度、相关性和不一致的解释。

结果

共有 23 名患者或父母/照顾者参与了研究(第一轮,n=10;第二轮,n=6;第三轮,n=7)。第 16 次访谈时达到数据饱和度。最常自发报告的体征/症状是:分泌物、眼红/粉红、瘙痒、肿胀/浮肿、泪眼、疼痛、灼热和异物感。瘙痒、疼痛/灼热/刺痛和异物感是最常报告的三个最困扰的症状。访谈结果表明,PRO 中的疼痛、瘙痒和异物感以及 ObsRO 中的疼痛或不适项目与患者的结膜炎体验相关,且清晰易懂。

结论

PRO 和 ObsRO 项目在评估成人和儿童患者的病毒性和细菌性结膜炎的关键症状时,被认为是清晰、相关和适当的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b48/6820993/d97096c1a1c5/12955_2019_1223_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b48/6820993/bdbcfe1aa605/12955_2019_1223_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b48/6820993/6916d5bd8576/12955_2019_1223_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b48/6820993/d97096c1a1c5/12955_2019_1223_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b48/6820993/bdbcfe1aa605/12955_2019_1223_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b48/6820993/6916d5bd8576/12955_2019_1223_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b48/6820993/d97096c1a1c5/12955_2019_1223_Fig3_HTML.jpg

相似文献

1
Content validity of a novel patient-reported and observer-reported outcomes assessment to evaluate ocular symptoms associated with infectious conjunctivitis in both adult and pediatric populations.评估成人和儿童人群与传染性结膜炎相关的眼部症状的新型患者报告和观察者报告结局评估的内容效度。
Health Qual Life Outcomes. 2019 Oct 30;17(1):163. doi: 10.1186/s12955-019-1223-9.
2
Development of the Patient- and Observer-Reported PRUCISION Instruments to Assess Pruritus and Sleep Disturbance in Pediatric Patients with Cholestatic Liver Diseases.开发患者和观察者报告的 PRUCISION 工具,以评估患有胆汁淤积性肝病的儿科患者的瘙痒和睡眠障碍。
Adv Ther. 2022 Nov;39(11):5126-5143. doi: 10.1007/s12325-022-02261-8. Epub 2022 Sep 6.
3
Assessing asthma symptoms in children: qualitative research supporting the development of the Pediatric Asthma Diary-Child (PAD-C) and Pediatric Asthma Diary-Observer (PAD-O).评估儿童哮喘症状:支持开发儿童哮喘日记-患儿(PAD-C)和儿童哮喘日记-观察者(PAD-O)的定性研究。
J Patient Rep Outcomes. 2023 Oct 20;7(1):104. doi: 10.1186/s41687-023-00639-y.
4
Development of a signs and symptoms outcome measure for caregivers of patients with methylmalonic acidemia and propionic acidemia (MMAPAQ).开发用于甲基丙二酸血症和丙酸血症(MMAPAQ)患者照顾者的症状和体征结局测量工具。
Mol Genet Metab. 2024 Sep-Oct;143(1-2):108577. doi: 10.1016/j.ymgme.2024.108577. Epub 2024 Sep 13.
5
Measuring dengue illness intensity: Development and content validity of the dengue virus daily diary (DENV-DD).衡量登革热疾病严重程度:登革热病毒日常日记(DENV-DD)的制定和内容效度。
J Patient Rep Outcomes. 2023 Aug 23;7(1):84. doi: 10.1186/s41687-023-00624-5.
6
Qualitative modification and development of patient- and caregiver-reported outcome measures for iron chelation therapy.铁螯合疗法患者及照料者报告结局指标的定性改进与发展
Health Qual Life Outcomes. 2017 Jun 23;15(1):129. doi: 10.1186/s12955-017-0702-0.
7
Qualitative exploration of the visual function impairments and impacts on vision-dependent activities of daily living in Retinitis Pigmentosa and Leber Congenital Amaurosis: content validation of the ViSIO-PRO and ViSIO-ObsRO measures.定性探索色素性视网膜炎和莱伯先天性黑矇患者的视觉功能障碍及其对视依赖日常生活活动的影响:ViSIO-PRO 和 ViSIO-ObsRO 测量的内容验证。
J Patient Rep Outcomes. 2023 Jul 19;7(1):74. doi: 10.1186/s41687-023-00610-x.
8
Development of an observer-reported outcome measure to capture the signs and impact of fever distress symptoms in infants and young children.开发一种由观察者报告的结局指标,以捕捉婴幼儿发热不适症状的体征及影响。
Qual Life Res. 2022 May;31(5):1573-1585. doi: 10.1007/s11136-021-03049-z. Epub 2022 Jan 7.
9
Development of patient- and observer-reported outcome measures to assess COVID-19 signs and symptoms in children and adolescents.开发患者和观察者报告的结局测量指标,以评估儿童和青少年的 COVID-19 体征和症状。
J Patient Rep Outcomes. 2023 Jan 26;7(1):7. doi: 10.1186/s41687-023-00542-6.
10
Content validity of a newly developed observer-reported measure for pediatric asthma in children aged 2-5 years.一种新开发的针对2至5岁儿童小儿哮喘的观察者报告测量方法的内容效度。
J Patient Rep Outcomes. 2022 May 28;6(1):55. doi: 10.1186/s41687-022-00461-y.

引用本文的文献

1
Understanding data visualization techniques in qualitative studies used to develop and validate patient-reported outcome measures: a targeted literature review.理解用于开发和验证患者报告结局指标的定性研究中的数据可视化技术:一项针对性文献综述。
Qual Life Res. 2025 Apr 25. doi: 10.1007/s11136-025-03964-5.
2
The e-cigarette assessment for youth-Revised (EAsY-R): Preliminary results of a pilot study of measure refinement via cognitive interviewing.电子香烟青少年评估修订版(EAsY-R):通过认知访谈进行测量细化的初步研究结果。
J Res Adolesc. 2024 Sep;34(3):845-856. doi: 10.1111/jora.12957. Epub 2024 Apr 28.

本文引用的文献

1
Clinician-Reported Outcome Assessments of Treatment Benefit: Report of the ISPOR Clinical Outcome Assessment Emerging Good Practices Task Force.治疗获益的临床医生报告结局评估:药物经济学与结局研究国际协会临床结局评估新兴良好实践特别工作组报告
Value Health. 2017 Jan;20(1):2-14. doi: 10.1016/j.jval.2016.11.005. Epub 2017 Jan 10.
2
Psychometric Properties of the Numerical Rating Scale to Assess Self-Reported Pain Intensity in Children and Adolescents: A Systematic Review.用于评估儿童和青少年自我报告疼痛强度的数字评分量表的心理测量特性:一项系统综述。
Clin J Pain. 2017 Apr;33(4):376-383. doi: 10.1097/AJP.0000000000000406.
3
Conjunctivitis: a systematic review of diagnosis and treatment.
结膜炎:诊断与治疗的系统综述。
JAMA. 2013 Oct 23;310(16):1721-9. doi: 10.1001/jama.2013.280318.
4
Efficacy and tolerability of besifloxacin ophthalmic suspension 0.6% administered twice daily for 3 days in the treatment of bacterial conjunctivitis: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study in adults and children.贝西沙星滴眼液 0.6%,每日 2 次,连续 3 天治疗细菌性结膜炎的疗效和耐受性:成人和儿童多中心、随机、双盲、对照、平行组研究。
Clin Ther. 2011 Jan;33(1):13-26. doi: 10.1016/j.clinthera.2010.12.004.
5
A randomised placebo-controlled trial of topical steroid in presumed viral conjunctivitis.一项关于疑似病毒性结膜炎局部皮质类固醇治疗的随机安慰剂对照试验。
Br J Ophthalmol. 2011 Sep;95(9):1299-303. doi: 10.1136/bjo.2010.188623. Epub 2011 Jan 20.
6
Pain in children: assessment and nonpharmacological management.儿童疼痛:评估与非药物治疗
Int J Pediatr. 2010;2010. doi: 10.1155/2010/474838. Epub 2010 Jul 25.
7
The treatment of acute infectious conjunctivitis with fusidic acid: a randomised controlled trial.用夫西地酸治疗急性感染性结膜炎:一项随机对照试验。
Br J Gen Pract. 2005 Dec;55(521):924-30.
8
Efficacy and safety of 0.5% levofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis in pediatric patients.0.5%左氧氟沙星滴眼液治疗小儿细菌性结膜炎的疗效与安全性
J AAPOS. 2003 Oct;7(5):317-24. doi: 10.1016/s1091-8531(03)00168-x.
9
Diagnostic impact of signs and symptoms in acute infectious conjunctivitis: systematic literature search.体征和症状在急性感染性结膜炎中的诊断影响:系统文献检索
BMJ. 2003 Oct 4;327(7418):789. doi: 10.1136/bmj.327.7418.789.
10
A phase III, placebo controlled clinical trial of 0.5% levofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis.一项关于0.5%左氧氟沙星滴眼液治疗细菌性结膜炎的III期、安慰剂对照临床试验。
Br J Ophthalmol. 2003 Aug;87(8):1004-9. doi: 10.1136/bjo.87.8.1004.